Please login to the form below

Not currently logged in
Email:
Password:

Sir Philip Hampton set to be new GSK chair

RBS chairman to replace Sir Christopher Gent

philip hampton gskGlaxoSmithKline (GSK) is set to name the Royal Bank of Scotland's (RBS) Sir Philip Hampton as the company's new chairman, according to local reports.

Several UK media outlets have published stories suggesting GSK will this week officially announce Sir Philip (pictured) as chairman-designate, replacing Sir Christopher Gent when he steps down in 2015.

The news come at a time of pressure for GSK after the company was recently hit with a $487m fine for illegal marketing practices in China.

Sir Philip has served as chairman of the board at RBS since 2009, overseeing the company during a time of global economic collapse.

He has experience in a wide variety of industries, with previous roles including chairman of Sainsbury's and as group finance directory at Lloyds TSB, BT Group, BG Group, British Gas and British Steel.

He is also a former chairman of UK Financial Investments Limited, which manages the UK Government's shareholdings in banks.


25th September 2014

From: Research, Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Wisepress

Wisepress is a medical bookseller promoting and selling books worldwide, both online and via the 200 European medical conferences that...

Latest intelligence

Precision paediatrics: Treating patients with CAR-T
Dr Stuart Adams specialises in using T-cell therapy to treat paediatric patients at Great Ormond Street Hospital. Here, he explains what it was like to develop and deliver a groundbreaking...
What does it mean to be an agile organisation
We spoke with Philip Atkinson to learn how healthcare and pharmaceutical companies can rapidly respond to changes in the market....
Battling breast cancer with precision medicine (Part 2)
Dr Mark Moasser treated breast cancer survivor Laura Holmes-Haddad (interviewed in part one) with an innovative precision medicine, which at the time was yet to be approved. Here he gives...

Infographics